{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:50:30Z","timestamp":1794016230342,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.euo.2025.04.027","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:49:38Z","timestamp":1747669778000},"page":"1505-1512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bladder Cancer with Undetectable Circulating Tumor DNA After Radical Cystectomy May Be Amenable to a Less Intense Imaging Surveillance Protocol: A Diagnostic Accuracy Study"],"prefix":"10.1016","volume":"8","author":[{"given":"Ahmed","family":"Eraky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Ben-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Hug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik P.","family":"Kolanukuduru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almoflihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Waingankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyrollis","family":"Attalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mehrazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Sfakianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.04.027_b0005","series-title":"EAU guidelines on muscle-invasive and metastatic bladder cancer","author":"Witjes","year":"2024"},{"key":"10.1016\/j.euo.2025.04.027_b0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/j.semnuclmed.2021.12.004","article-title":"PET\/CT in bladder cancer: an update","volume":"52","author":"Bouchelouche","year":"2022","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.euo.2025.04.027_b0015","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1186\/s12885-022-10310-2","article-title":"CT scans and cancer risks: a systematic review and dose-response meta-analysis","volume":"22","author":"Cao","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euo.2025.04.027_b0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00259-019-04452-y","article-title":"PET\/MRI versus PET\/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations","volume":"47","author":"Mayerhoefer","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.04.027_b0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/0974-7796.164852","article-title":"Disparities in long-term radiographic follow-up after cystectomy for bladder cancer: analysis of the SEER-Medicare database","volume":"8","author":"Alanee","year":"2016","journal-title":"Urol Ann"},{"key":"10.1016\/j.euo.2025.04.027_b0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.eururo.2022.04.013","article-title":"Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder","volume":"82","author":"Szabados","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.027_b0035","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.04.027_b0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/bju.16556","article-title":"Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomes","volume":"135","author":"Ben-David","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.04.027_b0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MOU.0000000000001221","article-title":"Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker","volume":"34","author":"Ben-David","year":"2024","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euo.2025.04.027_b0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euo.2024.07.001","article-title":"Association of tumor-informed circulating tumor DNA detectability before and after radical cystectomy with disease-free survival in patients with bladder cancer","volume":"8","author":"Sfakianos","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.04.027_b0055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1078-0432.CCR-21-2404","article-title":"Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, toward assessment of adjuvant therapy efficacy and clinical behavior of recurrences","volume":"28","author":"Henriksen","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2025.04.027_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12282-024-01556-8","article-title":"Liquid biopsy for breast cancer and other solid tumors: a review of recent advances","volume":"32","author":"Ohmura","year":"2025","journal-title":"Breast Cancer"},{"key":"10.1016\/j.euo.2025.04.027_b0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New Response Evaluation Criteria in Solid Tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2025.04.027_b0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.eururo.2024.05.014","article-title":"Whole-genome mutational analysis for tumor-informed detection of circulating tumor DNA in patients with urothelial carcinoma","volume":"86","author":"Nordentoft","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.027_b0075","doi-asserted-by":"crossref","unstructured":"Holzbeierlein J, Bixler BR, Buckley DI, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO guideline (2017; amended 2020, 2024). J Urol. Published online July 2024. https:\/\/doi.org\/10.1097\/JU.0000000000003981.","DOI":"10.1097\/JU.0000000000003981"},{"key":"10.1016\/j.euo.2025.04.027_b0080","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s11605-023-05761-2","article-title":"Diagnostic accuracy of carcinoembryonic antigen (CEA) in detecting colorectal cancer recurrence depending on its preoperative level","volume":"27","author":"Lee","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.euo.2025.04.027_b0085","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/EDBK_351033","article-title":"Best approaches and updates for prostate cancer biochemical recurrence","author":"Simon","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.euo.2025.04.027_b0090","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamaoncol.2019.0512","article-title":"Prognostic potential of circulating tumor DNA measurement in postoperative surveillance of nonmetastatic colorectal cancer","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.04.027_b0095","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/SLA.0000000000006386","article-title":"Tumor mutational burden from circulating tumor DNA predicts recurrence of hepatocellular carcinoma after resection: an emerging biomarker for surveillance","volume":"280","author":"Wehrle","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.euo.2025.04.027_b0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.1093","article-title":"Evaluation of comparative surveillance strategies of circulating tumor DNA, imaging, and carcinoembryonic antigen levels in patients with resected colorectal cancer","volume":"5","author":"Fakih","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.04.027_b0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-023-06225-y","article-title":"Practical recommendations for using ctDNA in clinical decision making","volume":"619","author":"Cohen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.euo.2025.04.027_b0110","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1177\/00031348231161750","article-title":"Utilization of circulating tumor DNA in the surveillance setting","volume":"89","author":"Gibbs","year":"2023","journal-title":"Am Surg"},{"key":"10.1016\/j.euo.2025.04.027_b0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1373\/jalm.2018.026393","article-title":"Circulating tumor DNA for early cancer detection","volume":"3","author":"Fiala","year":"2018","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.euo.2025.04.027_b0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.annonc.2022.11.005","article-title":"Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer","volume":"34","author":"Turner","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2025.04.027_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yao.2023.12.005","article-title":"Role of circulating tumor DNA for monitoring of recurrence and treatment response in urothelial cancer","volume":"4","author":"Au","year":"2024","journal-title":"Adv Oncol"},{"key":"10.1016\/j.euo.2025.04.027_b0130","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.e16606","article-title":"Correlation of circulating tumor DNA (ctDNA) dynamics with clinical response in patients with muscle-invasive bladder cancer (MIBC) undergoing trimodality therapy (TMT)","volume":"42","author":"Epstein","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.04.027_b0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44783","article-title":"Estimated cost of circulating tumor DNA for posttreatment surveillance of human papillomavirus\u2013associated oropharyngeal cancer","volume":"5","author":"Kowalchuk","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.04.027_b0140","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","article-title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","volume":"595","author":"Powles","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.euo.2025.04.027_b0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eururo.2023.06.007","article-title":"Updated overall survival by circulating tumor DNA status from the phase 3 IMvigor010 trial: adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma","volume":"85","author":"Powles","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.04.027_b0150","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.21037\/tau-24-7","article-title":"Towards circulating tumor DNA-guided treatment of muscle-invasive bladder cancer","volume":"13","author":"Lindskrog","year":"2024","journal-title":"Transl Androl Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:43:01Z","timestamp":1778143381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125001245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2588931125001245"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.04.027","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bladder Cancer with Undetectable Circulating Tumor DNA After Radical Cystectomy May Be Amenable to a Less Intense Imaging Surveillance Protocol: A Diagnostic Accuracy Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}